A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED). Background: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback